Shihai Lu

Shihai Lu

Takeda Pharmaceutical Company Limited - Osaka / Japan
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4631509
武田薬品工業株式会社
person_outline Shihai Lu's MOST POPULAR ARTICLES
1-) Regional differences in antithrombotic treatment for atrial fibrillation: insights from the GLORIA-AF Phase II RegistryM Mazurek, MV Huisman, KJ Rothman, M Paquette, C Teutsch, ...Thrombosis and haemostasis 117 (12), 2376-2388, 2017942017
2-) Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with …MV Huisman, KJ Rothman, M Paquette, C Teutsch, HC Diener, SJ Dubner, ...American Heart Journal 198, 55-63, 2018472018
3-) Persistence with dabigatran therapy at 2 years in patients with atrial fibrillationM Paquette, L Riou França, C Teutsch, HC Diener, S Lu, SJ Dubner, ...Journal of the American College of Cardiology 70 (13), 1573-1583, 2017472017
4-) Stroke‐prevention strategies in North American patients with atrial fibrillation: The GLORIA‐AF registry programWF McIntyre, D Conen, B Olshansky, JL Halperin, E Hayek, MV Huisman, ...Clinical cardiology 41 (6), 744-751, 2018362018
5-) Gender differences in antithrombotic treatment for newly diagnosed atrial fibrillation: the GLORIA-AF registry programM Mazurek, MV Huisman, KJ Rothman, M Paquette, C Teutsch, ...The American Journal of Medicine 131 (8), 945-955. e3, 2018332018